These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 30198851)
1. [Cost-effectiveness model of a fixed dose combination of solifenacin and tamsulosin for the treatment of LUTS associated with BPH with inadequate response to monotherapy.]. Alcántara A; Cózar JM; Errando C; Rubio-Rodríguez D; Rubio-Rodríguez D; Rubio-Terrés C; Mora AM; Duran A Arch Esp Urol; 2018 Sep; 71(7):595-606. PubMed ID: 30198851 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia. Nazir J; Heemstra L; van Engen A; Hakimi Z; Ivanescu C BMC Urol; 2015 May; 15():41. PubMed ID: 25956727 [TBL] [Abstract][Full Text] [Related]
3. Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE Study and NEPTUNE II open-label extension. Drake MJ; Chapple C; Sokol R; Oelke M; Traudtner K; Klaver M; Drogendijk T; Van Kerrebroeck P; Eur Urol; 2015 Feb; 67(2):262-70. PubMed ID: 25070148 [TBL] [Abstract][Full Text] [Related]
4. Combination therapy with solifenacin and tamsulosin oral controlled absorption system in a single tablet for lower urinary tract symptoms in men: efficacy and safety results from the randomised controlled NEPTUNE trial. van Kerrebroeck P; Chapple C; Drogendijk T; Klaver M; Sokol R; Speakman M; Traudtner K; Drake MJ; Eur Urol; 2013 Dec; 64(6):1003-12. PubMed ID: 23932438 [TBL] [Abstract][Full Text] [Related]
5. Responder and health-related quality of life analyses in men with lower urinary tract symptoms treated with a fixed-dose combination of solifenacin and tamsulosin oral-controlled absorption system: results from the NEPTUNE study. Drake MJ; Sokol R; Coyne K; Hakimi Z; Nazir J; Dorey J; Klaver M; Traudtner K; Odeyemi IA; Oelke M; van Kerrebroeck P; BJU Int; 2016 Jan; 117(1):165-72. PubMed ID: 25907003 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN). Van Kerrebroeck P; Haab F; Angulo JC; Vik V; Katona F; Garcia-Hernandez A; Klaver M; Traudtner K; Oelke M Eur Urol; 2013 Sep; 64(3):398-407. PubMed ID: 23537687 [TBL] [Abstract][Full Text] [Related]
7. A retrospective study of treatment persistence and adherence to α-blocker plus antimuscarinic combination therapies, in men with LUTS/BPH in the Netherlands. Drake MJ; Bowditch S; Arbe E; Hakimi Z; Guelfucci F; Amri I; Nazir J BMC Urol; 2017 May; 17(1):36. PubMed ID: 28532455 [TBL] [Abstract][Full Text] [Related]
8. Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia. Dimitropoulos K; Gravas S Drug Des Devel Ther; 2015; 9():1707-16. PubMed ID: 25834406 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of solifenacin plus tamsulosin oral controlled absorption system in men with lower urinary tract symptoms: a meta-analysis. Li MC; Wang ZY; Yang J; Guo XL; Wang T; Wang SG; Liu JH; Ye ZQ Asian J Androl; 2015; 17(1):124-34. PubMed ID: 25337836 [TBL] [Abstract][Full Text] [Related]
10. Combination therapy with tamsulosin and solifenacin for male lower urinary tract symptoms with predominant filling symptoms: a new approach to an old problem. Angulo JC Curr Med Res Opin; 2015 Nov; 31(11):1963-5. PubMed ID: 26368336 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of combination therapy for treatment of benign prostatic hyperplasia: a model based on the findings of the Combination of Avodart and Tamsulosin trial. Bjerklund Johansen TE; Baker TM; Black LK BJU Int; 2012 Mar; 109(5):731-8. PubMed ID: 21933326 [TBL] [Abstract][Full Text] [Related]
12. Tamsulosin combined with solifenacin versus tamsulosin monotherapy for male lower urinary tract symptoms: a meta-analysis. Gong M; Dong W; Huang G; Gong Z; Deng D; Qiu S; Yuan R Curr Med Res Opin; 2015; 31(9):1781-92. PubMed ID: 26211817 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of single-dose tamsulosin and dutasteride combination therapy compared with tamsulosin monotherapy in patients with benign prostatic hyperplasia in the UK. Walker A; Doyle S; Posnett J; Hunjan M BJU Int; 2013 Sep; 112(5):638-46. PubMed ID: 23356792 [TBL] [Abstract][Full Text] [Related]
14. Tamsulosin/solifenacin fixed-dose combination tablet for the treatment of male lower urinary tract symptoms. Romancik M; Pandian S; Drake MJ Drugs Today (Barc); 2014 Dec; 50(12):803-11. PubMed ID: 25588085 [TBL] [Abstract][Full Text] [Related]
15. Solifenacin plus tamsulosin combination treatment in men with lower urinary tract symptoms and bladder outlet obstruction: a randomized controlled trial. Kaplan SA; He W; Koltun WD; Cummings J; Schneider T; Fakhoury A Eur Urol; 2013 Jan; 63(1):158-65. PubMed ID: 22831853 [TBL] [Abstract][Full Text] [Related]
16. Drug treatment patterns for the management of men with lower urinary tract symptoms associated with benign prostatic hyperplasia who have both storage and voiding symptoms: a study using the health improvement network UK primary care data. Hakimi Z; Johnson M; Nazir J; Blak B; Odeyemi IA Curr Med Res Opin; 2015 Jan; 31(1):43-50. PubMed ID: 25333647 [TBL] [Abstract][Full Text] [Related]
17. Solifenacin and Tamsulosin Combination Therapy Decreases Urine Nerve Growth Factor/Creatinine Levels in Men. Chan R; Munoz A; Wenker EP; Whipple M; Miles B; Boone TB Urology; 2016 May; 91():150-3. PubMed ID: 26829718 [TBL] [Abstract][Full Text] [Related]
18. A cost effective analysis of fixed-dose combination of dutasteride and tamsulosin compared with dutasteride monotherapy for benign prostatic hyperplasia in Nigeria: a middle income perspective; using an interactive Markov model. Udeh EI; Ofoha CG; Adewole DA; Nnabugwu II BMC Cancer; 2016 Jul; 16():405. PubMed ID: 27388750 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Solifenacin and Trospium for Managing of Severe Symptoms of Overactive Bladder in Patients With Benign Prostatic Hyperplasia. Kosilov KV; Loparev SA; Ivanovskaya MA; Kosilova LV Am J Mens Health; 2016 Mar; 10(2):157-63. PubMed ID: 26186951 [TBL] [Abstract][Full Text] [Related]
20. Incidence of urinary retention during treatment with single tablet combinations of solifenacin+tamsulosin OCAS™ for up to 1 year in adult men with both storage and voiding LUTS: A subanalysis of the NEPTUNE/NEPTUNE II randomized controlled studies. Drake MJ; Oelke M; Snijder R; Klaver M; Traudtner K; van Charldorp K; Bongaerts D; Van Kerrebroeck P PLoS One; 2017; 12(2):e0170726. PubMed ID: 28166296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]